NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences have risen sharply over the first three days of trading in 2009.
Shares of the Cambridge, Mass.-based developer of single-molecule DNA sequencing systems are up nearly 300 percent so far this year from a Dec. 31 close of $.39 to today’s close of $1.49 on the Nasdaq.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.